The current study is designed to examine the airway inflammation in bronchial asthma by measuring the plasma levels of CXCL13 protein in patients with asthma exacerbation and to evaluate the expression of the CXCR5 receptor as a potential parameter to assess airway inflammation. This evidence concerns the gene CXCL13 and asthma.